Pathophysiology of pyoderma gangrenosum (PG): an updated review

Sara F Braswell1, Tassia C Kostopoulos1, Alex G Ortega-Loayza1

  • 1Department of Dermatology, Virginia Commonwealth University, Richmond, Virginia.

Insights

Pyoderma gangrenosum is a rare skin condition with complex causes. Understanding its pathogenesis is key for early diagnosis and developing targeted treatments.

Area of Science:

  • Dermatology
  • Immunology
  • Genetics

Background:

  • Pyoderma gangrenosum (PG) is a challenging ulcerative skin disease.
  • Diagnosis is clinical and often requires excluding other conditions like infection or neoplasia.
  • The multifactorial pathogenesis involves immune dysregulation and genetic factors.

Purpose of the Study:

  • To highlight the complexity of pyoderma gangrenosum pathogenesis.
  • To emphasize the need for improved diagnostic strategies.
  • To discuss the future of personalized therapies for PG.

Main Methods:

  • This study is a review of current understanding of pyoderma gangrenosum.
  • It synthesizes information on pathogenetic factors and treatment challenges.
  • No new experimental data was generated.

Main Results:

  • Pyoderma gangrenosum pathogenesis is complex, involving cytokines, immune cells, and genetics.
  • Current diagnostic methods rely on exclusion, leading to delays.
  • Treatment options are limited, and research is scarce.

Conclusions:

  • A deeper understanding of pyoderma gangrenosum's complex pathogenesis is crucial.
  • Early recognition and improved diagnosis are necessary.
  • Future research should focus on targeted and personalized therapies.

Related Concept Videos

Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.8K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
635
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
6.2K
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
76
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.7K
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.5K